B Group, Inc. Zai Lab LTD Transaction History
B Group, Inc.
- $117 Billion
- Q1 2025
A detailed history of B Group, Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, B Group, Inc. holds 400,000 shares of ZLAB stock, worth $12.5 Million. This represents 12.38% of its overall portfolio holdings.
Number of Shares
400,000
Previous 400,000
-0.0%
Holding current value
$12.5 Million
Previous $10.5 Billion
37.99%
% of portfolio
12.38%
Previous 6.4%
Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
175Shares Held
52.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$187 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$119 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$114 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$102 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$97.8 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.05B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...